39.4 F
New York
Friday, April 23, 2021

-

Home Health FDA authorizes one-dose COVID-19 vaccine

FDA authorizes one-dose COVID-19 vaccine

Document Analysis NLP IA

543
WORDS

WORDS
2:42
Reading Time

Reading Time
positive
sentiment

Sentiment0.12274489076815
subjective
redaction

Subjectivity0.51720469453028
probably it's an affirmation
Affirmation0.32758620689655

Highlights

RELEVANT
FREQ, RAKE or TFIDF
Entity
ORG
Entity
PERSON
Entity
PRODUCT
Entity
OTHER
Key Concepts (and relevance score)

Summary (IA Generated)

The Food and Drug Administration has authorized the Johnson & Johnson COVID-19 vaccine, which only needs one dose and can be stored in regular refrigerators.

The Johnson & Johnson vaccine is logistically easier to distribute than the Moderna and Pfizer / BioNTech vaccines, which take two doses and have to be stored in specialized freezers.

The Johnson & Johnson vaccine was built using a different technology than the Moderna and Pfizer / BioNTech vaccines.

It’s hard to directly compare COVID-19 vaccines because no clinical trials have studied them head-to-head.

The Moderna and Pfizer / BioNTech vaccines have higher efficacy on paper.

Clinical trials found that they were around 95 percent protective against symptomatic COVID-19.

The Moderna and Pfizer / BioNTech trials were tested in the US and other countries before variants appeared.

By one important measure, the vaccines are all pretty comparable: the Johnson & Johnson vaccine was just as good as the other two at protecting people from being hospitalized or dying from COVID-19.

“And Johnson & Johnson appears to be just as good as Moderna and Pfizer at preventing those.

”.

Johnson & Johnson has around 4 million doses, enough for 4 million people, ready to ship in the US.

Over 48 million people in the United States have already received at least one dose of a COVID-19 vaccine.


131FansLike
3FollowersFollow
16FollowersFollow